Clinical Trials in Jonesboro, Arkansas

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

NCT ID: NCT04674969

The ELEGANCE Registry is a clinical trial that aims to gather important information about the real-world use of drug-eluting devices made by Boston Scientific for treating peripheral vascular disea...

Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients

NCT ID: NCT04310020

This clinical trial is investigating a new treatment approach for patients with stage II or III non-small cell lung cancer (NSCLC). The study will look at how effective and safe it is to use radiat...

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

NCT ID: NCT05462145

This clinical trial is studying a new treatment called the Globe® Pulsed Field System for patients with symptomatic paroxysmal or persistent atrial fibrillation (AF). Atrial fibrillation is a commo...

SIMPLAAFY Clinical Trial

NCT ID: NCT06521463

The SIMPLAAFY Clinical Trial is studying the safety and effectiveness of two single-drug treatments compared to a combination of two antiplatelet drugs for patients who have received a WATCHMAN FLX...

Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

NCT ID: NCT06538038

This clinical trial is studying how well a medication called osimertinib, with or without chemotherapy, works for patients with advanced non-small cell lung cancer (NSCLC) that has a specific mutat...

Abbott Medical - VERITAS Study

NCT ID: NCT06707688

The VERITAS Study is a clinical trial designed to investigate the safety and effectiveness of a new device called the Amulet™ 2 Left Atrial Appendage occluder. This device is intended for patients ...

The CONFORM Pivotal Trial

NCT ID: NCT05147792

The CONFORM Pivotal Trial is studying a new device called the CLAAS® that aims to help patients with non-valvular atrial fibrillation (AF) reduce their risk of stroke. In this trial, eligible parti...

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

NCT ID: NCT05879926

This clinical trial is investigating whether adding chemotherapy to ovarian function suppression and hormone therapy can help prevent breast cancer from returning in premenopausal women with early-...

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

NCT ID: NCT06418204

This clinical trial is studying the effects of cannabis and cannabinoids—substances found in marijuana—on patients who have just been diagnosed with certain types of cancer, such as breast, colorec...

SELUTION4BTK Trial

NCT ID: NCT05055297

The SELUTION4BTK Trial is a clinical study designed to compare two treatments for patients with a serious condition called peripheral arterial disease (PAD), specifically for those suffering from c...

SELUTION4SFA Trial

NCT ID: NCT05132361

The SELUTION4SFA Trial is a clinical study that is looking at a new treatment option for people with Peripheral Arterial Disease (PAD), specifically in the superficial femoral artery (SFA) and the ...

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

NCT ID: NCT05478304

The Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial is a study designed to see if a specific procedure, called left atrial appendage exclusion (LAAE), can help prevent strok...

A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast Cancer

NCT ID: NCT06112379

This clinical trial is studying two different treatment approaches for patients with triple-negative breast cancer (TNBC) or hormone receptor-low/HER2-negative breast cancer. The goal is to see how...

IMpella-Protected cArdiaC Surgery Trial (IMPACT)

NCT ID: NCT05529654

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

NCT ID: NCT00271180

This clinical trial, called the Product Performance Report, is designed to assess how well certain heart devices made by Medtronic perform over a long period. These devices help manage heart condit...

Product Surveillance Registry

NCT ID: NCT01524276

The Product Surveillance Registry is a clinical trial that aims to monitor the safety and effectiveness of certain medical products made by Medtronic. This study will collect information from patie...

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

NCT ID: NCT03072927

This clinical trial is studying a procedure called MILD® (Minimally Invasive Lumbar Decompression) for patients with a condition known as lumbar spinal stenosis, which means there is pressure on th...

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

NCT ID: NCT06215716

This clinical trial is studying a medication called efruxifermin (EFX) to see if it can help people with non-cirrhotic Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steato...

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

NCT ID: NCT06256588

This clinical trial is studying a medication called Dostarlimab to see if it is safe and effective for adults with locally advanced head and neck cancer that cannot be surgically removed. Participa...

Selatogrel Outcome Study in Suspected Acute Myocardial Infarction

NCT ID: NCT04957719